ENTA vs TECH
Enanta Pharmaceuticals Inc (ENTA) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Enanta Pharmaceuticals Inc (ENTA) is a biotechnology company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported ENTA revenue for 2025-09-30 was $65.3M. Net income was -$81.9M. Revenue was down 3.4% from 2024-09-30 to 2025-09-30. ENTA currently screens at market cap $328.0M.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
ENTA currently screens at market cap $328.0M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the ENTA and TECH stock pages for the full models.
Not investment advice.